Publicaciones en las que colabora con Ana Patiño García (20)

2015

  1. Dietary total antioxidant capacity is associated with leukocyte telomere length in a children and adolescent population

    Clinical Nutrition, Vol. 34, Núm. 4, pp. 694-699

2014

  1. Sugar-sweetened carbonated beverage consumption and childhood/adolescent obesity: A case-control study

    Public Health Nutrition, Vol. 17, Núm. 10, pp. 2185-2193

2012

  1. Osteogénesis imperfecta: descripción de un caso

    Revista de hormona y factores de crecimiento, Vol. 15, Núm. 1, pp. 46-51

2008

  1. Serum Amyloid A Concentration is Increased in Obese Children and Adolescents

    Journal of Pediatrics, Vol. 153, Núm. 1, pp. 71-75

2007

  1. A novel mutation Thr162Arg of the melanocortin 4 receptor gene in a Spanish children and adolescent population

    Clinical Endocrinology, Vol. 66, Núm. 5, pp. 652-658

2006

  1. Bone mineral density and bone metabolism in children treated for bone sarcomas

    Pediatric Research, Vol. 59, Núm. 6, pp. 866-871

  2. Influencia del polimorfismo -866 G/A del gen de la UCP2 en población infantil obesa

    Nutricion Hospitalaria

2005

  1. No evidence of association between the serotonin 2A receptor -1438G/A promoter polymorphism and childhood obesity in a Spanish population: A case-parent study and a matched case-control study

    Nutritional Neuroscience, Vol. 8, Núm. 4, pp. 207-211

  2. Pediatric meningosarcoma: Clinical evolution and genetic instability

    Pediatric Neurology, Vol. 32, Núm. 5, pp. 352-354

2004

  1. Gene–gene interaction between PPARγ2 and ADRβ3 increases obesity risk in children and adolescents

    International Journal of Obesity, Vol. 28, pp. S37-S41

  2. Influence of two polymorphisms of the tumoral necrosis factor-α gene on the obesity phenotype

    Diabetes, Nutrition and Metabolism - Clinical and Experimental, Vol. 17, Núm. 1, pp. 17-22

  3. Polimorfismos genéticos en TNFalfa y PPARgamma2 y síndrome de resistencia a insulina

    Acta Diabetológica, Vol. 20, Núm. 1, pp. 33-40

2003

  1. Analysis of polymorphisms of the vitamin D receptor, estrogen receptor, and collagen Iα1 genes and their relationship with height in children with bone cancer

    Journal of Pediatric Hematology/Oncology, Vol. 25, Núm. 10, pp. 780-786

2002

  1. Measurement and analysis of the chemotherapy-induced genetic instability in pediatric cancer patients

    Mutagenesis, Vol. 17, Núm. 2, pp. 171-175

2000

  1. Alteraciones genéticas inducidas por los tratamientos antitumorales en pacientes pediátricos con cáncer: carcinogénesis química

    Anales del sistema sanitario de Navarra, Vol. 23, Núm. 1, pp. 7-17

  2. Análisis de la implicación de los genes de supresión tumoral TP53, p16INK4, p21WAF1, RB1 y de las enzimas metabolizadoras de drogas en el desarrollo de tumores óseos en niños

    Anales del sistema sanitario de Navarra, Vol. 23, Núm. 1, pp. 25-34

  3. Characteristics and value of chromosome aberrations induced by antitumor treatments in pediatric patients with cancer

    Revista de medicina de la Universidad de Navarra, Vol. 44, Núm. 1, pp. 15-24

  4. Nonclonal chromosomal aberrations induced by anti-tumoral regimens in childhood cancer: Relationship with cancer-related genes and fragile sites

    Cancer Genetics and Cytogenetics, Vol. 121, Núm. 1, pp. 78-85

  5. Obesity in children

    Revista de medicina de la Universidad de Navarra, Vol. 44, Núm. 4, pp. 29-44

1999

  1. Clinical and molecular features of Ewing sarcoma in a patient with triple-X syndrome

    Cancer Genetics and Cytogenetics, Vol. 113, Núm. 2, pp. 188-190